Skip to content
2000
Volume 13, Issue 1
  • ISSN: 1875-6921
  • E-ISSN: 1875-6913

Abstract

Background: Individual drug response arises from the interplay between genes and the environment. Pharmacometabolomics, is an alternative, but complementary discipline to pharmacogenomics, aiming to predict or evaluate response to treatment. Methods: Data for this perspective article were identified by searches of PubMed and references from relevant articles using the search terms "pharmacogenomics", "pharmacometabolomics", and "personalized medicine". Only articles published in English between 2002 and 2015 were included. Results: This perspective article on pharmacometabolomics focuses on the current applications of this holistic approach and presents the challenges that still need to be met. Conclusion: The merge of pharmacogenomics with pharmacometabolomic data, rapidly and efficiently, remains a significant challenge. No doubt, a “pharmacometabolomics-informed pharmacogenomic” strategy is anticipated to enable our in-depth understanding of individual variations in drug response phenotypes and hence, the design of individualized therapeutic approaches via the prediction of metabotypes.

Loading

Article metrics loading...

/content/journals/cppm/10.2174/1875692113666150818221334
2015-04-01
2025-10-21
Loading full text...

Full text loading...

/content/journals/cppm/10.2174/1875692113666150818221334
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test